Mocker Lena, Hildenbrand Ralf, Oyama Tsuneo, Sido Bernd, Yahagi Naohisa, Dumoulin Franz Ludwig
Department of Medicine and Gastroenterology, Gemeinschaftskrankenhaus Bonn, Academic Teaching Hospital, University of Bonn, Bonn, Germany.
Institute für Pathology Bonn-Duisdorf, Bonn, Germany.
Endosc Int Open. 2019 Apr;7(4):E446-E451. doi: 10.1055/a-0854-3610. Epub 2019 Mar 21.
Current guidelines recommend endoscopic submucosal dissection (ESD) as a treatment option for early cancers of the upper gastrointestinal tract with absent or minimal risk of lymph node metastasis. However, due to the low prevalence of these entities, it is difficult to achieve a competence level for ESD of upper gastrointestinal tract cancers in the Western World. Here, we present single-center data on the implementation of upper gastrointestinal ESD after previous experience with 89 colorectal ESD cases. Retrospective case series of 39 consecutive patients with early cancers of the esophagus (n = 13) or cardia and stomach (n = 26) treated with ESD over a 4-year period. ESD was technically feasible in all cases with en bloc, R0, and curative resection rates of 100 %, 76.9 %, and 71.8 %, respectively, and a mean procedure time of 100 minutes (30 - 360 minutes). After an initial 20 procedures, the R0 and curative resection rates increased from 65.0 % to 89.5 %, and from 60.0 % to 84.2 %, respectively. Complications were observed in four patients (10.3 %): three perforations, one case of delayed bleeding, and one esophageal stricture. No case required emergency surgery; the 30-day mortality rate was 0 %. In this modest case series from Europe, we observed an effectiveness and complication rate for ESD for early esophageal and gastric cancer that are comparable to other series from Europe but also to more abundant data from Asia. The results indicate that even small numbers of upper gastrointestinal cancers can be managed adequately in centers with expertise in colorectal ESD.
当前指南推荐内镜黏膜下剥离术(ESD)作为上消化道早期癌症的一种治疗选择,这些癌症发生淋巴结转移的风险不存在或极低。然而,由于这些疾病的发病率较低,在西方世界很难达到上消化道癌症ESD的专业水平。在此,我们呈现了在先前有89例结直肠ESD病例经验之后开展上消化道ESD的单中心数据。对39例连续患者进行回顾性病例系列研究,这些患者为食管(n = 13)或贲门及胃(n = 26)的早期癌症,在4年期间接受了ESD治疗。ESD在所有病例中技术上都是可行的,整块切除率、R0切除率和根治性切除率分别为100%、76.9%和71.8%,平均手术时间为100分钟(30 - 360分钟)。在最初的20例手术后,R0切除率和根治性切除率分别从65.0%提高到89.5%,从60.0%提高到84.2%。4例患者(10.3%)出现并发症:3例穿孔、1例迟发性出血和1例食管狭窄。无一例需要急诊手术;30天死亡率为0%。在这个来自欧洲的适度病例系列中,我们观察到早期食管癌和胃癌ESD的有效性和并发症发生率与欧洲的其他系列相当,但也与来自亚洲的更丰富数据相当。结果表明,即使是少量的上消化道癌症,在具有结直肠ESD专业知识的中心也能得到充分的治疗。